This speculation was supported by a subsequent study providing the first evidence that the improvement of cardiac remodeling by empagliflozin observed in rats with and without diabetes subjected to ligation of the left anterior descending coronary artery was linked with the upregulation of cGCH1 and then with the activation of eNOS. The gene discussed is NOS3; the disease is diabetes mellitus.